Speakers included members of the House of Representatives and representatives of the American Civil Liberties Union, the Office of Technology Assessment, the Epilepsy Foundation of America, the General Accounting Office, the Congressional Budget Office, and the Federal Executive and Professional Association. They focused on the accuracy of the tests, their expense, their relationship to constitutional protections of privacy, and the extent of drug abuse in the Federal workforce. They also suggested other approaches for dealing with drug abuse, including employee assistance programs, supervisory training, and procedures for employees to seek counseling and rehabilitation services voluntarily. Written testimony.